Surgery Partners, Inc.
SGRY
$13.97
$0.191.38%
NASDAQ
| 03/31/2026 | 12/31/2025 | 09/30/2025 | 06/30/2025 | 03/31/2025 | |
|---|---|---|---|---|---|
| Net Income | 4.77% | 86.18% | 28.39% | 83.87% | -204.03% |
| Total Depreciation and Amortization | 6.06% | 76.70% | -21.31% | 15.80% | 7.72% |
| Total Amortization of Deferred Charges | -- | -- | -- | -- | -- |
| Total Other Non-Cash Items | -8.71% | -64.64% | 13.75% | -29.18% | 12.61% |
| Change in Net Operating Assets | 12.83% | 41.59% | 34.75% | 22.33% | -50.93% |
| Cash from Operations | 95.00% | -7.18% | 28.22% | -1.81% | -85.26% |
| Capital Expenditure | 29.52% | 42.60% | 1.98% | 13.01% | -8.10% |
| Sale of Property, Plant, and Equipment | -- | 227.27% | -- | -- | 220.00% |
| Cash Acquisitions | 90.45% | -25.00% | 82.71% | 98.10% | 19.41% |
| Divestitures | -- | -- | -- | -- | -- |
| Other Investing Activities | 146.90% | -155.17% | -678.57% | -19.44% | -61.11% |
| Cash from Investing | 82.46% | -12.89% | 6.85% | 100.86% | 8.06% |
| Total Debt Issued | -8.52% | 160.44% | -24.05% | -84.71% | 10.96% |
| Total Debt Repaid | -62.45% | -239.82% | -19.26% | 78.90% | 0.75% |
| Issuance of Common Stock | -- | -- | -- | -- | -- |
| Repurchase of Common Stock | -- | -- | -- | -- | -- |
| Issuance of Preferred Stock | -- | -- | -- | -- | -- |
| Repurchase of Preferred Stock | -- | -- | -- | -- | -- |
| Total Dividends Paid | -- | -- | -- | -- | -- |
| Other Financing Activities | 10.30% | -13.71% | -25.31% | 14.41% | -57.88% |
| Cash from Financing | -285.10% | 23.33% | -1,052.05% | -133.02% | -4.73% |
| Foreign Exchange rate Adjustments | -- | -- | -- | -- | -- |
| Miscellaneous Cash Flow Adjustments | -- | -- | -- | -- | -- |
| Net Change in Cash | -43.28% | -23.48% | -662.65% | -26.50% | -275.70% |